Mevalonic acid (lithium salt)
| Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
|---|---|---|---|---|---|
| HY-113071A-1MG | 1mg | 97,00 | 63,10 | Add | |
| HY-113071A-5MG | 5 mg | 266,00 | 172,90 | Add | |
| HY-113071A-1ML | 10mM/1mL | 292,00 | 189,80 | Add | |
| HY-113071A-10MG | 10 mg | 326,00 | 211,90 | Add | |
| HY-113071A-50MG | 50 mg | 612,00 | 397,80 | Add | |
| HY-113071A-100MG | 100 mg | 1'144,00 | 743,60 | Add | |
| HY-113071A-250MG | 250 mg | 2'075,00 | 1'348,80 | Add | |
| HY-113071A-500MG | 500 mg | 3'405,00 | 2'213,30 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Promotion runs until 31.12.2024Year-End Promotion : 35% discount on the entire MedChem Express portfolio
MVA (lithium salt)
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease; Neurological Disease; Cardiovascular Disease; Cancer |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic);H2O : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 3 |
| Purity | 99.8% |
| Molecular Formula | C6H11LiO4 |
| Molecular Weight | 154.09 |
| CAS-Number | 2618458-93-6 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
